The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Original Article

Serological Differences in Folate/Vitamin B12 in Pregnancies Affected by Neural Tube Defects

Authors: Irina Cech, PhD, Keith D. Burau, PhD

Abstract


Background: Laboratory evidence is presented of significant associations between reduced maternal serum folate and vitamin B12 levels and neural tube birth defects (NTD) compared to referents.


Methods: This was an incident case-control study. Cases of neural tube defects (including anencephaly and open spina bifida) diagnosed in residents within 100 miles of the US-Mexico border from January 1993 to October 2000 were eligible. Most cases were diagnosed in utero upon visits to clinics, obstetrical or genetic expert offices. Cases identified upon hospital admission or at delivery were also eligible. Cases identified after discharge were not. Controls were matched on geographic region, maternal age, race/ethnicity, gestational age, and type of health insurance (including none).


Results: Three hundred eighty-two border area residents (107 cases and 275 individually matched controls) provided biological specimens. Median folate concentrations for case mothers were 36% lower than controls (9.8 ng/mL vs. 15 ng/mL). Maternal serum folate concentrations in quartiles above 9.5 ng/mL indicated significantly reduced risk (OR = 0.4, OR = 0.3, and OR = 0.2). Likewise, the risk for NTD decreased (OR = 0.4, OR = 0.3, and OR = 0.2) in quartiles of sera B12 concentrations above 246 pg/mL.


Conclusions: Physician attention is invited to significantly lower concentrations of serum folate and vitamin B12 in women with NTD-affected pregnancies. This study assayed sera samples from women while still pregnant or immediately after delivery. The confounding effect of reduced folate and B12 levels with other biological and chemical exposures will be addressed in subsequent communications.



This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Cech I, Burau KD, Al-Hashimi R, et al. Chemical and biological factors associated with neural tube defect births along Texas-Mexico border. Report to the Agency for Toxic Substances and Disease Registry, December 2005. Atlanta, GA.
 
2. Gunter EW, Miller DT. Laboratory Procedures Used by the Division of Environmental Health Laboratory Sciences, Center for Environmental Health, Centers for Disease Control, for the Hispanic Health and Nutrition Examination Survey (HHANES) 1982–1984. Atlanta, GA, Centers for Disease Control, 1986, pp 24–26.
 
3. Suarez L, Hendricks KA, Cooper SP, et al. Neural tube defects among Mexican Americans living on the US-Mexico border: effects of folic acid and dietary folate. Am J Epidemiol 2000;152:1017–1023.
 
4. Moore LL, Bradlee ML, Singer MR, et al. Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology 2003;14:200–205.
 
5. Centers for Disease Control. Preventing Neural Tube Defects: A Prevention Model and Resource Guide. Atlanta, Georgia, US Department of Health and Human Services, CDC, 1998.
 
6. Czeizel AE, Tóth M, Rockenbauer M. Population-based case control study of folic acid supplementation during pregnancy. Teratology 1996;53:345–351.
 
7. Persad VL, Van den Hoff MC, Dubé JM, et al. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 2002;167:241–245.
 
8. Hertrampf E, Cortés F. Folic acid fortification of wheat flour: Chile. Nutr Rev 2004;62:S44–S48; discussion S49.
 
9. Stevenson RE, Allen WP, Pai GS, et al. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 2000;106:677–683.
 
10. Honein AM, Paulozzi LJ, Mathews TJ, et al. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981–2986.
 
11. Shaw GM, Lammer EJ, Zhu H, et al. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 2002;108:1–6.
 
12. Wald NJ, Hackshaw AD, Stone R, et al. Blood folic acid and vitamin B12 in relation to neural tube defects. Br J Obstet Gynaecol 1996;103:319–324.
 
13. Bower C, Stanley FJ. Dietary folate as a risk for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989;150:613–619.
 
14. Wild J, Schorah CJ, Sheldon TA, et al. Investigation of factors influencing folate status in women who have had a neural tube defect- affected infant. Br J Obstet Gynaecol 1993;100:546–549.
 
15. Shaw GM, Schaffer D, Velie EM, et al. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6:219–226.
 
16. Ratan SK, Rattan KN, Pandey RM, et al. Evaluation of the levels of folate, vitamin B12, homocysteine and fluoride in the parents and the affected neonates with neural tube defect and their matched controls. Pediatr Surg Int 2008;24:803–808.